Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 20/20 | 0.82 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30967340 | 0.99 | FOLH1 (0.80) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL29598755 | 0.99 | FOLH1 (0.80) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL15278119 | 0.90 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL17849920 | 0.90 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL18412142 | 0.88 | FOLH1 (0.85) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL26001427 | 0.88 | FOLH1 (0.71) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL17849539 | 0.86 | FOLH1 (0.92) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL10060822 | 0.86 | FOLH1 (0.81) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL13177561 | 0.86 | FOLH1 (0.81) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL17573461 | 0.86 | FOLH1 (0.64) | FOLH1RIMKLANAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114364405-B | Prostate Specific Membrane Antigen (PSMA) inhibitors as diagnostic and radionuclide therapeutics | 五一一制药股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-108541302-B | Urea-based Prostate Specific Membrane Antigen (PSMA) inhibitors for imaging and therapy | 五一一制药股份有限公司 | 2023-02-14 | — | — | CN | disclosed |
| CN-114364405-A | Prostate Specific Membrane Antigen (PSMA) inhibitors as diagnostic agents and radionuclide therapeutics | 五一一制药股份有限公司 | 2022-04-15 | — | — | CN | disclosed |